Background:  Modern supraannular aortic xenografts offer a special design, thus providing maximized opening area for improved hemodynamics. The aim of this study was a prospectively randomized comparison of the Trifecta and the Perimount Magna Ease valves based on metric annulus sizing.

Methods:  A total of 100 patients with aortic stenosis undergoing aortic valve replacement (AVR) with or without concomitant procedures were prospectively included. After decalcification of the annulus, stratified intraoperative randomization was performed. The diameter of the aortic annulus was measured using metric Hegar dilators and randomization was based on this metric annulus diameter. Exercise echocardiography was performed at 10-month follow-up.

Results:  Mean age was 69 years, with 36% female. Predominant implanted valve sizes were 23 mm (39%) and 25 mm (32%). Unadjusted mean pressure gradient was significantly lower and effective orifice area larger for the Trifecta group (10.8 ± 5 vs. 13.2 ± 4 mm Hg,  = 0.02 and 1.93 ± 0.39 vs. 1.70 ± 0.30 cm,  = 0.002) at discharge. In patients with small annuli, based on the metric annulus size there were no significant differences in gradients or the orifice area. At exercise echocardiography follow-up, there were no significant hemodynamic differences between both prostheses.

Conclusions:  The Trifecta and the Perimount Magna Ease prostheses both show excellent hemodynamic performance after AVR. In patients with larger annuli, the Trifecta valve seems to be even superior to the Magna Ease, which may be advantageous in obese patients.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1637011DOI Listing

Publication Analysis

Top Keywords

magna ease
16
trifecta perimount
12
perimount magna
12
based metric
12
metric annulus
12
randomized comparison
8
comparison trifecta
8
supraannular aortic
8
exercise echocardiography
8
orifice area
8

Similar Publications

Aortic valve replacement (AVR) in a patient with a bio-Bentall conduit can be very challenging, especially if there was a previous endocarditis process for significant morbidity and mortality. We report a case of sutureless AVR in an old patient with a bio-Bentall conduit (Carpentier-Edwards Perimount Magna Ease 25 aortic valve and Hemashield 30 aortic conduit), who developed an endocarditis on aortic prosthesis valve. We believe that sutureless AVR is the best option for redo-operation in older patients with a high surgical risk because it allows for easy rapid deployment implantation, avoids anchoring sutures on a fragile aortic anulus, and reduces cardiopulmonary and aortic cross-clamp times.

View Article and Find Full Text PDF

Adaptation of Aortic Bioprosthetic Valves for Pulmonary Position: Comparative Analysis of Transcatheter and Surgical Valves.

J Cardiovasc Transl Res

December 2024

Department of Mechanical and Materials Engineering, University of Denver, 2155 E. Wesley Ave, Room 439, Denver, CO, 80208, USA.

Article Synopsis
  • Pulmonary valve dysfunction is frequent in congenital heart disease, often requiring procedures like right ventricular outflow tract reconstruction, with transcatheter pulmonary valve replacement (TPVR) now being a successful alternative to traditional surgery.
  • This study compares two bioprosthetic valves: the Carpentier Edwards Perimount Magna Ease surgical valve and the Edwards SAPIEN 3 transcatheter valve, noting that the latter was originally designed for aortic use but has been adapted for pulmonary applications.
  • Significant differences were observed in the hydrodynamic and structural characteristics of the valves under pulmonary and aortic conditions, enhancing the understanding of the biomechanics involved in both surgical and transcatheter replacements.
View Article and Find Full Text PDF

Comparison of four aortic bioprostheses: Hancock II St Jude Trifecta Carpentier-Edwards Perimount Magna Magna Ease-mid-term results (COMPARE SAVR study).

J Thorac Dis

August 2024

CAROL-Cardiothoracic Anatomy Research Operative Lab, Department of Cardiovascular Surgery and Transplantology, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

Background: In the era of percutaneous aortic valve implantation, biological valves are the preferred prostheses implanted in patients undergoing surgical aortic valve replacement (sAVR). The aim was to present a real-life analysis of mid-term sAVR outcomes for the four aortic bioprostheses: the Hancock II, the Carpentier-Edwards Perimount Magna, the Carpentier-Edwards Perimount Magna Ease and the Trifecta valve.

Methods: This is a retrospective study based on data from the Polish National Cardiac Surgery Database.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares early clinical and hemodynamic outcomes of three types of bioprosthetic valves used in surgical aortic valve replacement: Magna Ease, Intuity, and Inspiris Resilia.
  • Data from 2589 patients revealed that the Intuity valve had the shortest aortic cross clamp time, while Inspiris showed the lowest permanent pace-maker implantation rates.
  • All devices demonstrated excellent outcomes, but Inspiris had the best overall performance with lower gradient measurements compared to the Magna Ease valve.
View Article and Find Full Text PDF
Article Synopsis
  • The mitris valve combines features of two existing valves—the Carpentier-Edwards PERIMOUNT Magna Mitral Ease valve and INSPIRIS RESILIA tissue—for enhanced hemodynamic performance and durability.
  • Its design includes a more flexible, saddle-shaped sewing cuff that fits the mitral valve better, reducing risks of complications during double-valve replacements.
  • The valve also benefits from advanced technology that minimizes free aldehyde levels, suggesting improved long-term durability and reliability compared to earlier models.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!